A glance at some of the day's highlights from the Proactive Investors newswire
OKYO Pharma Limited (LON:OKYO; OTCQB:EMMLF) said a non-opioid analgesic it is developing has shown early potential to treat acute and chronic ocular pain.
DeepVerge PLC (LON:DVRG) said it has signed a non-binding memorandum of understanding (MOU) with China Resources Environmental Protection Development Limited, a subsidiary of China Resources Group, to enter into a joint venture (JV) for the manufacturing and sale of environmental monitoring equipment.
Keywords Studios PLC (LON:KWS) founder Giorgio Guastalla has sold 3mln shares at 2,800p each. Following the sale, non-executive director Guastalla will own just over 500,000 shares, a 0.7% stake.